Success Story: NIW Approval Secured For A Biomaterials Researcher From China With Our Expert Guidance

Client’s Testimonial:

 

“Thank you very much for the support throughout the process.”

 


 

On September 17th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. Student in the Field of Regenerative Biomaterials (Approval Notice).

 


 

General Field: Regenerative Biomaterials

 

Position at the Time of Case Filing: Ph.D. Student

 

Country of Origin: China

 

State of Residence at the Time of Filing: California

 

Approval Notice Date: September 17th, 2026

 

Processing Time: 2 months, 11 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

Holding an M.S. in oral and maxillofacial surgery, the client currently conducts advanced research at a major U.S. academic research institution. Furthermore, his endeavor advances federally recognized Critical and Emerging Technologies in biotechnology and aligns with National Institutes of Health (NIH) initiatives in regenerative medicine.

 

Demonstrating Extraordinary Scientific Value

 

To satisfy the second prong of Matter of Dhanasar, North America Immigration Law Group (Chen Immigration Law Associates) structured a comprehensive evidentiary strategy showing that the client is exceptionally well-positioned to advance his endeavor:

 

  • High-Impact Scholarly Record: Authored 5 peer-reviewed journal articles in top-tier periodicals, 1 conference abstract, and 2 granted patents.
  • Contextualized Citation Influence: Evaluated his 26 citations through bibliometric analysis, demonstrating that one of his key publications ranked among the top 20% most-cited clinical medicine articles for its publication year.
  • Federal Validation & Independent Reliance: Documented major research support funded by the National Institutes of Health (NIH) and highlighted independent research teams incorporating his digital surgical planning and nanocarrier delivery frameworks.

 

The petition was further corroborated by an expert recommendation letter attesting to the clinical necessity and national importance of his regenerative biomaterials research.

 

Conclusion

 

By connecting the client’s advanced degree credentials, patent output, bibliometric standing, federal grant backing, and independent scholarly reliance, our firm successfully secured his I-140 NIW approval. We congratulate the client and look forward to his continued contributions to regenerative medicine and public health in the United States.